Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Masimo Corporation - Common Stock (NQ: MASI )

169.69 +4.00 (+2.41%)
Streaming Delayed Price Updated: 3:09 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Masimo Corporation - Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
19 20 Next >
MASIMO CORPORATION SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Masimo Corporation (NASDAQ: MASI)
From Bernstein Liebhard LLP
Via GlobeNewswire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Masimo Corporation (MASI) Investors
From Law Offices of Howard G. Smith
Via Business Wire
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Masimo Corporation (MASI) Investors
From Kirby McInerney LLP
Via Business Wire
What 7 Analyst Ratings Have To Say About Masimo
Via Benzinga
Why Shares of Masimo Are Dropping Tuesday
The company's preliminary second-quarter numbers have investors worried. 
Via The Motley Fool
MASI INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Masimo Corporation Investors with Substantial Losses Have Opportunity to Lead the Masimo Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Masimo Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – MASI
From The Rosen Law Firm, P.A.
Via Business Wire
Shareholder Alert: Robbins LLP Informs Shareholders of Class Action Filed Against Masimo Corporation
From Robbins LLP
Via Business Wire
Masimo Announces Full Market Release of Stork™ Smart Home Baby Monitor
From Masimo
Via Business Wire
New Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Elderly Patients Undergoing Gastrointestinal Surgery
From Masimo
Via Business Wire
Masimo Reports Second Quarter 2023 Financial Results
From Masimo Corporation
Via Business Wire
New Study Finds That Masimo SedLine® Patient State Index (PSi) Has the Potential to Improve Brain Monitoring for Patients Sedated with Dexmedetomidine
From Masimo
Via Business Wire
Masimo, Medical Device Maker Drops on Q2 Guidance, Opportunity?
Shares of Masimo are at their lowest level since January 2019 — but according to Wall Street, could have healthy gains ahead. 
Via MarketBeat
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Masimo Corporation (MASI) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Masimo Corporation (MASI) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Masimo Corporation (MASI) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Nasdaq Futures Rise As Focus Turns To Tesla, Netflix Q2 Prints: Analyst Says Earnings Need Some 'Heavy Lifting' For Sustained Rally
Via Benzinga
Nasdaq Gains Over 100 Points; Lockheed Martin Profit Tops Expectations
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Tuesday. The Dow traded up 1.09% to 34,961.65 while the NASDAQ rose 0.91% to 14,374.77.... 
Via Benzinga
Delay In Large Orders, Lower Inpatient Census To Ail Masimo's Q2 Results, Analyst Lowers Estimates
Needham analyst Mike Matson reiterated a Buy rating on Masimo Corporation (NASDAQ: MASI), lowering the  
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  During Tuesday's trading, 46 companies set new 52-week lows. 
Via Benzinga
Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) gained 90% to $0.3560 after the company issued strategic update and announced restructuring. 
Via Benzinga
Dow Jumps Over 300 Points; Morgan Stanley Posts Upbeat Earnings
U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 300 points on Tuesday. The Dow traded up 1% to 34,932.08 while the NASDAQ rose 0.34% to 14,293.55. The S&P 500, also... 
Via Benzinga
Masimo Plummets To Five-Year Low On Light Sales, 'Longer-Term' Challenges Persist
The company works primarily in health care, but its non-health care efforts are floundering. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For July 18, 2023
Via Benzinga
CMG Stock Alert: Chipotle Announces International Expansion Plan
Chipotle Mexican Grill (CMG) stock is in the news Tuesday after the restaurant chain announced plans for an international expansion. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Is CEL-SCI (CVM) Stock Down 23% Today?
CEL-SCI (CVM) stock is dropping on Tuesday after the biotechnology company announced details of a public share offering. 
Via InvestorPlace
Why Is Masimo (MASI) Stock Down 30% Today?
Masimo (MASI) stock is taking a beating on Tuesday after the patient monitoring tech company released preliminary earnings for Q2 2023. 
Via InvestorPlace
Why Biophytis Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarket
Gainers Biophytis S.A. (NASDAQ: BPTS) shares surged 53.9% to $3.31 in pre-market trading after the company signed a partnership with SEQENS to produce Sarconeos (BIO101) active compound, the company's... 
Via Benzinga
Masimo Analysts Cut Their Forecasts Following Preliminary Q2 Results
Masimo Corporation (NASDAQ: MASI) reported weak preliminary revenue results for the second quarter. 
Via Benzinga
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.